title: [Sirolimus-associated interstitial pneumonitis in a renal transplant patient].
abstract: BACKGROUND
  Sirolimus is a new immunosuppressive drug used in organ transplantation, particularly in renal transplantation. In the future, it could replace calcineurin inhibitors such as cyclosporine. It is currently associated with side effects, such as thrombocytopenia and hyperlipidemia. Several interstitial pneumonitis associated with sirolimus has been previously described in renal transplant recipients associated with marked general symptoms.
  
  
  METHODS
  We report on a 65-year-old renal recipient presenting with a non typical case of sirolimus interstitial pneumonitis. He presented with fever and marked general symptoms for several months. CT scan showed a unilateral interstitial pneumonitis. After infectious, inflammatory and tumoral diseases were ruled out, sirolimus associated interstitial pneumonitis was evoked. The patient improved quickly after discontinuation of sirolimus.
  
  
  CONCLUSIONS
  It is important to evoke, after eliminating other aetiologies, sirolimus induced pneumonitis in face of an organ transplant recipient presenting with marked general symptoms even if the pulmonary symptoms are not predominant.
authors.affiliation: Service de Médecine Interne, Hôpital Bichat-Claude-Bernard, 46, rue Henri-Huchard, 75877 Paris cedex 18, France.
authors.forename: C
authors.initials: C
authors.lastname: Bauer
authors.forename: O
authors.initials: O
authors.lastname: Lidove
authors.forename: C
authors.initials: C
authors.lastname: Lamotte
authors.forename: T
authors.initials: T
authors.lastname: Petit
authors.forename: D
authors.initials: D
authors.lastname: Lieberherr
authors.forename: M P
authors.initials: MP
authors.lastname: Chauveheid
authors.forename: C
authors.initials: C
authors.lastname: Legendre
authors.forename: B
authors.initials: B
authors.lastname: Crestani
authors.forename: M C
authors.initials: MC
authors.lastname: Dombret
authors.forename: J P
authors.initials: JP
authors.lastname: Laissy
authors.forename: C
authors.initials: C
authors.lastname: Antoine
authors.forename: B
authors.initials: B
authors.lastname: Pegaz-Fiornet
authors.forename: T
authors.initials: T
authors.lastname: Papo
mesh_terms: D000368:Aged; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D001999:Bronchoscopy; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D020123:Sirolimus / Q000009:adverse effects*; D014057:Tomography, X-Ray Computed
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus